Previous Article | Next Article ![]()
Journal of Virology, October 2000, p. 9786-9791, Vol. 74, No. 20
Department of Viral Oncology, Institute for Virus
Research,1 and Department of Medical
Chemistry and Molecular Biology, Graduate School of
Medicine,2 Kyoto University, Sakyo-ku, Kyoto
606-8507, Japan
Received 27 March 2000/Accepted 24 July 2000
In contrast to wild-type mouse mammary tumor virus (MMTV), the MMTV
mutants with specific deletions in the U3 region of their long terminal
repeats cause T-cell lymphomas. In 30% of T-cell lymphomas arising in
BALB/c mice infected with MLA-MMTV, a leukemogenic MMTV mutant, we have
found that MMTV proviruses were integrated into a short region of the
Notch1 genome, so that truncated Notch1 transcripts encoding the transmembrane and the cytoplasmic domains of
Notch1 protein could be expressed. Thus, Notch1 is a major target of provirus insertional mutagenesis in these T-cell lymphomas.
Mouse mammary tumor virus (MMTV) is
associated primarily with induction of mammary adenocarcinomas. Wnt,
fibroblast growth factor, and Notch gene families have been
identified as the major cellular proto-oncogenes activated by
integrated MMTV proviruses in mammary tumors (reviewed in references
4, 11, 15, and 35). However, in
mice with active MMTVs (such as the DBA/2 and GR strains), variants of
MMTV provirus with specific deletions of about 350 to 500 nucleotides
in the U3 region of the long terminal repeat (LTR) often associate with
spontaneously developed T-cell lymphomas (9, 20, 22, 23,
36). Moreover, type B leukemogenic virus (TBLV), a MMTV variant
with similar LTR alteration, induces T-cell lymphomas in mice after a
very short (ca. 50-day) latency period (2, 3). We have
previously cloned the rearranged LTRs from extra MMTV proviruses
present in two DBA/2 mouse lymphoma cell lines, MLA and DL-8, and
showed that these rearranged LTRs exhibit marked transcriptional
activities in T-cell lines (36) compared with the wild-type
LTRs. Hsu et al. also demonstrated that MMTV provirus in T-cell
lymphomas lack a negative regulatory element in the LTR
(14). These results suggested that these MMTV proviruses
acquire a selective advantage in lymphocytes by specific LTR
alterations. Furthermore, by using an infectious MMTV provirus clone
(31), we have constructed pathogenic MMTV proviruses with
these rearranged LTRs and demonstrated that these MMTV variants do
induce T-cell lymphomas in adult BALB/c mice after an average latency
period of 30 weeks, but they no longer induce mammary tumors
(37). These results provided direct evidence that the small
deletion of specific LTR sequences is necessary and sufficient to
convert target tissue of MMTV transformation.
Notch family genes encode transmembrane receptor proteins
mediating signals which regulate various cell fate decisions that involve cell-cell interactions (reviewed in reference
1). To date, four members of this family have been
identified in the mouse. The extracellular domain of the Notch protein
contains signal peptide, 29 epidermal growth factor (EGF)-like repeats (the binding site of the Delta-Serrate-Lag2 family of ligand proteins), and 3 Notch/lin-12 repeats. The intracellular domain contains a RAM
domain (34) and Cdc10/ankyrin repeats, both of which can bind the RBP-J/CBF-1 transcription factor. Recent studies showed that
ligand binding induces proteolytic cleavage of Notch protein and that
the cleaved intracellular form of Notch makes a complex with
RBP-J/CBF-1, translocates into the nucleus, and regulates transcription
of target genes (7, 32; reviewed in reference 5). Loss of the extracellular domain of the Notch
protein causes constitutive activation of the protein and thus is known
to be associated with tumorigenesis. MMTV or intracisternal type A
particle provirus integration at the Notch4/int3 locus leads
to expression of a truncated Notch4/int3 protein which
causes mouse mammary tumors (11, 17, 18). Similar MMTV
provirus-mediated activation of Notch1 has been reported in
mouse mammary tumors (8). On the other hand, in line with
the cell fate regulatory function of Notch1 during T-cell
development (25, 30), an association of Notch1
rearrangement with T-cell lymphoma induction has been reported: in
human T-cell acute lymphoblastic leukemia, the chromosomal translocation t(7;9) joins a portion of Notch1/Tan1 to the
T-cell receptor Currently, two common provirus integration sites, Tblvi1
(24) and c-myc (28) have been found in
TBLV-induced T-cell lymphomas, but the gene(s) activated at the
Tblvi1 locus is unidentified. In addition, the cellular
proto-oncogenes activated by other leukemogenic MMTV in T-cell
lymphomas remain unknown. We report here that Notch1 is a
major target of provirus insertional mutagenesis in the T-cell lymphoma
arising in a leukemogenic MMTV-infected BALB/c mouse. Provirus
integrations led to the generation of truncated Notch1 transcripts which encode the transmembrane and the cytoplasmic domains
of Notch1 protein.
Rearrangement of the Notch1 gene in T-cell lymphomas
developed in MLA-MMTV-infected BALB/c mice.
We have analyzed by
Southern blotting whether rearrangement of the Notch1 gene
occurred in 73 T-cell lymphomas developed in BALB/c mice which were
infected with a strain of leukemogenic MMTV, MLA-MMTV (37).
The following five Notch1 cDNA fragments were prepared from
pmNotch1 (19), the pBluescript II SK(+) containing the
entire coding region of mouse Notch1 cDNA and used as probes for Southern and Northern blot analyses: probe 1, a 0.6-kb
BamHI-SacI fragment encoding from the C terminus
of the EGF-like repeats to a point located between Notch/lin-12 repeats
and the transmembrane domain; probe 2, a 0.5-kb
PstI-KpnI fragment encoding from the Notch/lin-12
repeats to the N terminus of the transmembrane domain; probe 3, a
2.0-kb ClaI fragment encoding from the N terminus to the
middle of the EGF repeats; probe 4, a 1.5-kb NotI fragment encoding from the cdc10/ankyrin repeat to the C terminus; and probe 5, a 0.3-kb fragment encoding the RAM domain (16) which was
amplified by PCR using the sense primer RAM-S
(5'-CGGCGCCAGCATGGCCAGCTCTGG-3', corresponding to nucleotide
positions 5329 to 5352 of Notch1) and the antisense primer
RAM-AS (5'-CTGAGGCGGTGTTGGGGCCAT-3', corresponding to
nucleotide positions 5620 to 5640). In addition, a 1.2-kb
BamHI-BglII fragment encoding env of
MMTV provirus (31, 37) was used to analyze MMTV provirus
integration. (The positions of these probes are shown schematically
[see Fig. 2].) Southern blotting with Notch1 probes 1 and
2 revealed that rearrangement of the Notch1 genome occurred
in 34% (25 of 73) of the T-cell lymphomas screened. Eight tumors
giving rise to rearranged Notch1 genomic DNA fragments which
were equimolar relative to the germ line Notch1 genomic DNA
fragments were selected for further analysis. The results of Southern
blot analysis of these eight tumors and normal spleen cells (used as a
control) are shown in Fig. 1. The blot
with MMTV env probe showed that DNAs of all lymphomas
contained several newly acquired host-virus junction fragments, which
were unique for each tumor, indicating that each tumor originated from a single or a few clones which were infected with MMTV (Fig. 1, top
panel). The rearrangement of the Notch1 genome in these
lymphomas is shown in the second and third panels of Fig. 1; in
addition to the 4.2-kb BamHI fragment derived from the
unaffected Notch1 allele, Notch1 probe 1 hybridized with an additional BamHI fragment which is unique
for each tumor. Similarly, in addition to the 2.2-kb PstI
fragments derived from the Notch1 unaffected allele, Notch1 probe 2 hybridized with an additional PstI
fragment in five tumors. To confirm the location and orientation of the
MLA-MMTV provirus inserted in each tumor, PCR analysis was performed.
According to the expected orientation of the provirus, one of the
following sense primers from the MLA-MMTV LTR sequence (shown in Fig.
2B) was used in combination with an
antisense primer from the Notch1 exon F sequence (named
Notch1-F-AS, 5'-GAAGGCGGCCGCTGCCACGTACATGAGGTG-3', corresponding to nucleotide positions 5251 to 5280 of
Notch1 cDNA [Fig. 2A]); MMTV-LTR-U5
(5'-CCCGTCTCCGCTCGTCACTTATC-3',
corresponding to the sense strand of the LTR U5 sequence)
and MMTV-LTR-U3-RV (5'-GTGTAGGACACTCTCGGGAGT-3',
corresponding to the antisense strand of the LTR U3 sequence).
The MMTV-LTR-U5 and MMTV-LTR-U3-RV primers were used when provirus was
integrated in the same and in the opposite transcriptional
orientations, respectively, as the Notch1 gene. The length
of the PCR products amplified from tumor DNAs was then determined (data
not shown). Based on these Southern blotting and PCR results and
restriction maps of the unaffected Notch1 allele, the
integration site and the orientation of MMTV provirus in the rearranged
Notch1 allele was determined in each tumor (Fig. 2A). The
provirus integrated into lymphoma 55, however, seems to have a deletion
in the 3' part of provirus including the env gene (data not
shown).
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Identification of Notch1 as a Frequent Target for
Provirus Insertional Mutagenesis in T-Cell Lymphomas Induced by
Leukemogenic Mutants of Mouse Mammary Tumor Virus


![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
locus (10); transplantation with bone
marrow cells expressing activated Notch1 allele led to
exclusive development of T-cell neoplasms in mice (27); and
the Notch1 gene is known to be a target of provirus
insertions in T-cell lymphomas arising in Moloney murine leukemia
virus (Mo-MuLV)-infected MMTVD/myc
transgenic mice, a transgenic mouse bred on a CD1 background which
overexpresses the c-myc gene under the control of TBLV LTR (12, 13, 26). In this case, collaboration of
c-myc and Notch1 for oncogenesis was suggested,
because frequent integration of Mo-MuLV proviruses in the
Notch1 allele was observed in lymphomas arising in
myc transgenic mice but not in nontransgenic littermates (12).

View larger version (73K):
[in a new window]
FIG. 1.
Southern blot hybridization demonstrating the
rearrangement of the Notch1 locus in T-cell lymphomas
arising in MLA-MMTV-infected BALB/c mice. The MLA strain of the
leukemogenic recombinant MMTV was described previously (36,
37). Southern blotting was performed as described earlier
(18, 36). Genomic DNAs (20 µg) from eight representative
MLA-MMTV-induced T-cell lymphomas (the identification number of each
tumor is shown at the top) and normal BALB/c mouse spleens were
digested with restriction endonucleases, Southern blotted, and
hybridized. The restriction enzyme and the probe used are indicated on
the left side of each panel. Numbers on the right indicate the
migration positions of DNA molecular size markers (in kilobases).

View larger version (24K):
[in a new window]
FIG. 2.
Schematic representation of the proviruses integrated
within the Notch1 gene in MLA-MMTV-induced T-cell lymphomas.
(A) Rearranged regions of the Notch1 genome are shown
together with a schematic representation of the full-length
Notch1 cDNA. Exons and introns are indicated by open boxes
and solid lines, respectively. Consistent with previous reports
(8, 12, 13), the exons are labeled C, D, E, and F. The
vertical arrows indicate the sites of provirus integration. The
horizontal arrow with a number shows the transcriptional orientation of
provirus in each tumor. The structural features of Notch1
cDNA are indicated: EGF-R (EGF-like repeats), NLR (Notch/lin-12
repeats), TM (transmembrane domain), RAM (RAM23 homologous domain), ANK
(Cdc10/ankyrin repeats), OPA (opa repeats), and PEST (PEST sequence
motif). The probes used in Southern and Northern analyses are indicated
by bars. The positions of the Notch1-F-AS, RAM-S, and RAM-AS primers
are indicated by open arrows. (B) The structure of MLA-MMTV provirus is
schematically presented. The positions of the MMTV env probe
and the MMTV-LTR-U5 and the MMTV-LTR-U3-RV primers are indicated by a
bar and open arrows, respectively. Restriction sites: B,
BamHI; K, KpnI; P, PstI; S,
SacI; Bg, BglII; R, EcoRI.
Expression of truncated Notch1 transcripts in lymphomas
with Notch1 gene rearrangements.
To determine whether
provirus insertion affected Notch1 gene expression, a
Northern blot analysis was performed with probes encoding the
intracellular (probe 4) or the extracellular (probe 3) region of
Notch1 protein. The eight MLA-MMTV-induced lymphomas described above, as well as lymphoma 2, an MLA-MMTV- induced
T-cell lymphoma with normal Notch1 alleles, were subjected
to this analysis (Fig. 3). High levels of
expression of 2.5- to 4.0-kb transcripts solely hybridized with the
intracellular probe were detected in all of the lymphomas with
Notch1 gene rearrangements (Fig. 3, the second panel),
suggesting that these truncated RNA encode the intracellular domain of
the Notch1 protein. In addition, in some lymphomas (i.e., lymphomas 7, 11, and 16), marked expressions of 7.5- to 8.5-kb transcript were
detected with this probe. On the other hand, 7.0- to 7.5-kb
transcripts, which solely hybridized with the extracellular probe, were
also detected in some lymphomas (lymphoma 7, 11, 17, 43, and 53 in Fig.
3, top panel). In contrast, no Notch1 transcript was
detected in lymphoma 2. Basically, these results indicated that
provirus insertion commonly induced RNA species, which could encode the
intracellular domain of Notch1. Since the provirus had integrated in
the direction of Notch1 gene transcription in lymphomas 7, 17, and 43, the proviral 3' LTR appears to function as a promoter for
the Notch1 transcripts of about 2.5 kb detected with the
intracellular probe. In the same lymphomas, on the other hand, marked
expression of ~7.0-kb transcripts, which solely hybridized with the
extracellular probe, was also detected. Probably, the 5' LTR of the
integrated provirus provided not only enhancer(s) to the
Notch1 promoter to achieve high levels of Notch1
transcription but also a transcriptional termination signal. This might
be the mechanism generating the Notch1 transcripts of 7.0 kb. In lymphomas 11 and 16, expression of 8- to 9-kb RNA species which
hybridized with both extracellular and intracellular probes was
detected (Fig. 3, top panel). The mechanism generating these
Notch1 transcripts is not clear, but the following is
possible: some sequence in the integrated provirus may have provided
enhancer(s) for Notch1 promoter, which led to transcription
of entire Notch1 gene even in the presence of integrated
provirus (assuming that the provirus integrated in the opposite
orientation as that in lymphoma 16 could not provide transcriptional
termination signal). Then, the Notch1 RNA species encoding
both extracellular and intracellular domains of Notch1 were generated
by RNA splicing.
|
Structure of the truncated Notch1 transcripts.
To
define the structure of the 2.5-kb Notch1 transcripts solely
hybridized with the intracellular probe, and possibly their mode of
production as well, lymphomas 7, 43, and 45 were chosen, and the 5'
regions of their Notch1 transcripts were analyzed by reverse
transcription-PCR (RT-PCR) (Fig. 4).
Single-stranded cDNAs were synthesized from total RNAs from these
lymphomas using the SuperScript Preamplification System for First
Strand cDNA Synthesis (Gibco-BRL, Gaithersburg, Md.). In the case of
lymphomas 7 and 43, where the provirus is integrated in the same
transcriptional orientation to Notch1, the cDNA fragment
containing sequences of the U5 region of MMTV LTR and the
Notch1 RAM domain was amplified by RT-PCR with the
single-stranded cDNAs synthesized and a set of primers (sense primer
MMTV-LTR-U5 and antisense primer RAM-AS). In case of lymphoma 45, however, in which the provirus is integrated in an orientation opposite
to that of Notch1, we assumed that truncated transcripts
originated from a cryptic promoter within the provirus and that
sequences in the reverse strand in the MMTV LTR U3 might be transcribed
and constitute a part of the MMTV-Notch1 chimeric
transcript. As expected, RT-PCR with MMTV-LTR-U3-RV and RAM-AS primers
generated a 0.78-kb product which hybridized with Notch1
probe 5 (data not shown). The PCR products thus obtained were blunted
and phosphorylated with T4 DNA polymerase (NEB) and with T4
polynucleotide kinase (NEB), respectively, and then cloned into the
EcoRV site of pBluescript II KS(+) by blunt-end ligation. Sequence analysis revealed that the RT-PCR product obtained from lymphoma 7 was a 0.62-kb DNA fragment whose sequence corresponded to a
chimeric virus-Notch1 RNA that started in the LTR (from
MMTV-LTR-U5 primer) and was followed by the Notch1 cDNA
sequence that started and ended at nucleotide positions 5102 (middle of
exon E) and 5640 (position of the RAM-AS primer), respectively. On the
other hand, the RT-PCR product from lymphoma 43 was a 0.56-kb DNA
fragment corresponding to a chimeric virus-Notch1 RNA that
started in the LTR and was followed by 93 nucleotides of the
Notch1 intron sequence adjacent to exon F and the
Notch1 cDNA sequence that started and ended at nucleotide
positions 5216 (first nucleotide of exon F) and 5640, respectively.
Furthermore, the RT-PCR product from lymphoma 45 was a 0.78-kb DNA
fragment corresponding to a chimeric virus-Notch1 RNA that
started in the MMTV-LTR-U3 and was followed by 161 nucleotides of the
Notch1 intron sequence adjacent to exon E and
Notch1 cDNA sequence that started and ended at nucleotide
positions 5067 (first nucleotide of exon E) and 5640, respectively. In
all of cases, chimeric virus-Notch1 RNAs used the ATG codon
at nucleotide position 5257 (located just N-terminal to the
transmembrane domain in exon F) of Notch1 cDNA as an
initiation methionine to generate the truncated Notch1
proteins consisting of the transmembrane and intracellular domains. In
lymphomas in which the provirus is integrated in an orientation
opposite to that of Notch1, however, structure of the 5'
part of the MMTV-Notch1 chimeric transcripts hybridizing with the intracellular probe remains unknown, and their generation mechanism is not clear. In this regard, Girard et al. (12)
have analyzed the structure of similar Notch1 transcripts in
lymphomas in which Mo-MuLV had integrated in the opposite orientation
to Notch1 and reported following two modes of generation for
these transcripts: (i) the enhancer in the 5' LTR of the integrated provirus activated a cryptic promoter within the intronic
Notch1 sequence to yield the truncated transcripts and (ii)
some distinct truncated transcripts originated from a cryptic promoter
within the provirus itself. In our MLA-MMTV-induced tumor cases, the second mode may be operative in lymphoma 45. However, the first mode is
also possible because we previously identified a T-lymphocyte-specific enhancer in the U3 region of the MLA LTR (at nucleotide positions 536 to 557 of the U3 sequence [36]). In any case, these
results further substantiated the notion that Notch proteins lacking
the extracellular domain are tumorigenic. However, the molecular
mechanism(s) by which these truncated Notch proteins induce tumors
remains to be elucidated.
|
| |
ACKNOWLEDGMENTS |
|---|
We thank T. Oikawa (Sasaki Institute) and N. Tsuchida (Tokyo Medical and Dental University) for c-myc and the p53 plasmid, respectively. We also thank A. B. Sorensen and F. S. Pedersen for the Sint1 genomic probe.
This work was supported by a grant-in-aid from the Ministry of Education, Science, Sports, and Culture of Japan to S.-I.Y.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Viral Oncology, Institute for Virus Research, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan. Phone: 81-75-751-3996. Fax: 81-75-751-3995. E-mail: syanagaw{at}virus.kyoto-u.ac.jp.
Present address: Department of Pathology, Harvard Medical School,
Boston, MA 02115.
Present address: Department of Molecular and Experimental
Medicine, The Scripps Research Institute, La Jolla, CA 92037.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Artavanis-Tsakonas, S.,
M. D. Rand, and R. J. Lake.
1999.
Notch signaling: cell fate control and signal integration in development.
Science
284:770-776 |
| 2. | Ball, J. K., and G. A. Dekaban. 1987. Characterization of early molecular events associated with thymic lymphoma induction following infection with a thymotropic type-B retrovirus. Virology 161:357-365[CrossRef][Medline]. |
| 3. |
Ball, J. K.,
H. Diggelmann,
G. A. Dekaban,
G. F. Grossi,
R. Semmler,
P. A. Waight, and R. F. Fletcher.
1988.
Alteration on the U3 region of the long terminal repeat of an infectious thymotropic type B retrovirus.
J. Virol.
62:2985-2993 |
| 4. | Callahan, R. 1996. MMTV induced mutations in mouse mammary tumors: their potential relevance to human breast cancer. Breast Cancer Res. Treatment 39:33-44[CrossRef][Medline]. |
| 5. | Chan, Y.-M., and Y. N. Jan. 1998. Roles for proteolysis and trafficking in Notch maturation and signal transduction. Cell 94:423-426[CrossRef][Medline]. |
| 6. | Del Amo, F. F., M. Gendron-Maguire, P. J. Swiatek, N. A. Jenkins, N. G. Copeland, and T. Gridley. 1993. Cloning, analysis, and chromosomal localization of Notch-1, a mouse homolog of Drosophila Notch. Genomics 15:259-264[CrossRef][Medline]. |
| 7. | De Strooper, B., W. Anneart, P. Cupers, P. Safting, K. Craessaerts, L. S. Munn, E. H. Schroeter, V. Schrijvers, M. S. Wolfe, W. J. Ray, A. Goate, and R. Kopan. 1999. A presenilin-1-like dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398:518-522[CrossRef][Medline]. |
| 8. | Dievart, A., N. Beaulieu, and P. Jolicoeur. 1999. Involvement of Notch1 in the development of mouse mammary tumors. Oncogene 18:5973-5981[CrossRef][Medline]. |
| 9. |
Dudley, J., and R. Risser.
1984.
Amplification and novel locations of mouse mammary tumor virus genomes in mouse T-cell lymphomas.
J. Virol.
49:92-101 |
| 10. | Ellisen, L. W., J. Bird, D. C. West, A. L. Soreng, T. C. Reynolds, S. D. Smith, and J. Sklar. 1991. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66:649-661[CrossRef][Medline]. |
| 11. | Gallahan, D., and R. Callahan. 1997. The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4). Oncogene 14:1883-1890[CrossRef][Medline]. |
| 12. |
Girard, L.,
Z. Hanna,
N. Beaulieu,
C. D. Hoemann,
C. Simard,
C. A. Kozak, and P. Jolicoeur.
1996.
Frequent provirus insertional mutagenesis of Notch1 in the thymomas of MMTVD/myc transgenic mice suggest a collaboration of c-myc and Notch1 for oncogenesis.
Genes Dev.
10:1930-1944 |
| 13. | Girard, L., and P. Jolicoeur. 1998. A full-length Notch1 allele is dispensable for transformation associated with a provirally activated truncated Notch1 allele in MuLV-infected MMTVD/myc transgenic mice. Oncogene 16:517-522[CrossRef][Medline]. |
| 14. |
Hsu, C.-L. L.,
C. Fabritius, and J. Dudley.
1988.
Mouse mammary tumor virus provirus in T-cell lymphomas lack a negative regulatory element in the long terminal repeat.
J. Virol.
62:4644-4652 |
| 15. | Jonkers, J., and A. Berns. 1996. Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochem. Biophys. Acta 1287:29-57[Medline]. |
| 16. | Kato, H., T. Sakai, K. Tamura, S. Minoguchi, Y. Shirayoshi, Y. Hamada, Y. Tsujimoto, and T. Honjo. 1996. Functional conservation of mouse Notch receptor family members. FEBS Lett. 395:221-224[CrossRef][Medline]. |
| 17. | Kordon, E. C., G. H. Smith, R. Callahan, and D. Gallahan. 1995. A novel non-mouse mammary tumor virus activation of the int-3 gene in a spontaneous mouse mammary tumor. J. Virol. 69:8066-8069[Abstract]. |
| 18. |
Lee, J.-S.,
T. Haruna,
A. Ishimoto,
T. Honjo, and S. Yanagawa.
1999.
Intracisternal type A particle-mediated activation of the Notch4/int3 gene in a mouse mammary tumor: generation of truncated Notch4/int3 mRNAs by retroviral splicing events.
J. Virol.
73:5166-5171 |
| 19. | Lee, J.-S., A. Ishimoto, T. Honjo, and S. Yanagawa. 1999. Murine leukemia provirus-mediated activation of the Notch1 gene leads to induction of HES-1 in a mouse T lymphoma cell line, DL-3. FEBS Lett. 455:276-280[CrossRef][Medline]. |
| 20. | Lee, W. T.-L., O. Prakash, D. Klein, and N. H. Sarker. 1987. Structural alteration in the long terminal repeat of an acquired mouse mammary tumor virus provirus in a T-cell leukemia of DBA/2 mice. Virology 159:39-48[CrossRef][Medline]. |
| 21. | Majors, J. E., and H. E. Varmus. 1983. Nucleotide sequencing of an apparent proviral copy of env mRNA defines determinants of expression of the mouse mammary tumor virus env gene. J. Virol. 70:495-504. |
| 22. | Michalides, R., and E. Wagenaar. 1986. Site-specific rearrangements in the long terminal repeat of extra mouse mammary tumor proviruses in murine T-cell leukemias. Virology 154:76-84[CrossRef][Medline]. |
| 23. |
Michalides, R.,
E. Wagenaar,
J. Hilkins,
J. Hilgers,
B. Groner, and N. E. Hynes.
1982.
Acquisition of proviral DNA of mouse mammary tumor virus in thymic leukemia cells from GR mice.
J. Virol.
43:819-829 |
| 24. | Mueller, R. E., L. Baggio, C. A. Kozak, and J. K. Ball. 1992. A common integration locus in type B retrovirus-induced thymic lymphomas. Virology 191:628-639[CrossRef][Medline]. |
| 25. | Osborne, B., and I. Miele. 1999. Notch and the immune system. Immunity 11:653-663[CrossRef][Medline]. |
| 26. |
Panquette, Y.,
L. Doyon,
A. Laperriere,
Z. Hanna,
J. Ball,
R. P. Sekaly, and P. Jolicoueur.
1992.
A viral longterminal repeat expressed in CD4+ CD8+ precursors is downregulated in mature peripheral CD4 CD8+ or CD4+ CD8 T cells.
Mol. Cell. Biol.
12:3522-3530 |
| 27. |
Pear, W. S.,
J. C. Aster,
M. L. Scott,
R. P. Hasserjian,
B. Soffer,
J. Sklar, and D. Baltimore.
1996.
Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch allele.
J. Exp. Med.
183:2283-2291 |
| 28. |
Rajan, L.,
D. Brroussard,
M. Lozano,
C. G. Lee,
C. A. Kozak, and J. P. Dudley.
2000.
The c-myc locus is a common integration site in type B retrovirus-induced T-cell lymphomas.
J. Virol.
74:2466-2471 |
| 29. | Rajan, L., and J. P. Dudley. 1997. An MMTV integration site maps near the distal end of mouse chromosome 11. Mamm. Genome 8:295-296[CrossRef][Medline]. |
| 30. | Robey, E., D. Chang, A. Itano, D. Cado, H. Alexander, D. Lans, G. Weinmaster, and P. Salmon. 1996. An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell 87:483-492[CrossRef][Medline]. |
| 31. |
Shackleford, G. M., and H. E. Varmus.
1988.
Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative vector.
Proc. Natl. Acad. Sci. USA
85:9655-9659 |
| 32. | Schroter, E. H., J. A. Kissinger, and R. Kopan. 1998. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393:382-386[CrossRef][Medline]. |
| 33. |
Sorensen, A. B.,
A. H. Lund,
S. Ethelberg,
N. G. Copeland,
N. J. Jenkins, and F. S. Pedersen.
2000.
Sint1, a common integration site in SL3-3-induced T-cell lymphomas, harbors a putative proto-oncogene with homology to the septin gene family.
J. Virol.
74:2161-2168 |
| 34. | Tamura, K., Y. Taniguchi, S. Minoguchi, T. Sakai, T. Tun, T. Furukawa, and T. Honjo. 1995. Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-Jk/Su(H). Curr. Biol. 5:1416-1423[CrossRef][Medline]. |
| 35. | van Leeuwen, F., and R. Nusse. 1995. Oncogene activation and oncogene cooperation in MMTV-induced mouse mammary cancer. Semin. Cancer Biol. 6:127-133[CrossRef][Medline]. |
| 36. |
Yanagawa, S.,
A. Murakami, and H. Tanaka.
1990.
Extra mouse mammary tumor proviruses in DBA/2 mouse lymphomas acquire a selective advantage in lymphocytes by alteration in the U3 region of the long terminal repeat.
J. Virol.
64:2474-2483 |
| 37. |
Yanagawa, S.,
K. Kakimi,
H. Tanaka,
A. Murakami,
Y. Nakagawa,
Y. Kubo,
Y. Yamada,
H. Hiai,
K. Kuribayashi,
T. Masuda, and A. Ishimoto.
1993.
Mouse mammary tumor virus with rearranged long terminal repeats causes murine lymphomas.
J. Virol.
67:112-118 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»